Reata Pharma
(RETA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 12,732 | 12,501 | 12,551 | 12,366 | 12,438 |
| Gross Profit | 12,732 | 12,501 | 12,551 | 12,366 | 12,438 |
| Operating Expenses | 19,906 | 16,737 | 13,509 | 13,791 | 12,701 |
| Operating Income | -7,174 | -4,236 | -958 | -1,425 | -263 |
| Interest Expense | 5 | 0 | 0 | 0 | 0 |
| Other Income | 81 | 101 | 62 | 28 | 23 |
| Pre-tax Income | -7,098 | -4,135 | -896 | -1,397 | -240 |
| Income Tax | N/A | 1 | 1 | -461 | 18 |
| Net Income Continuous | -7,098 | -4,136 | -897 | -936 | -258 |
| Net Income | $-7,098 | $-4,136 | $-897 | $-936 | $-258 |
| EPS Basic Total Ops | -0.32 | -0.20 | -0.04 | -0.05 | -0.02 |
| EPS Basic Continuous Ops | -0.32 | -0.21 | -0.04 | -0.05 | -0.02 |
| EPS Diluted Total Ops | -0.32 | -0.20 | -0.04 | -0.05 | -0.02 |
| EPS Diluted Continuous Ops | -0.32 | -0.21 | -0.04 | -0.05 | -0.02 |
| EBITDA(a) | $-7,044 | $-4,091 | $-788 | $-1,246 | $-75 |